Position in LLY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$716,645,230
-$136,211,223 QoQ
Shares Held
779,157
-1.8% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $5,042,614,731 across 16 Drug Manufacturers - General names. LLY ranks #4 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,489,121 | $1,097,320,733 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,291,826 | $997,423,745 | |
| 3 | ABBV |
AbbVie Inc.
|
3,732,204 | $811,717,043 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
779,157 | $716,645,230 | |
| 5 | AMGN |
Amgen Inc
|
1,555,021 | $547,134,134 | |
| 6 | PFE |
Pfizer Inc
|
9,769,180 | $274,318,571 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,202,321 | $167,567,475 | |
| 8 | AZN |
Astrazeneca PLC
|
684,404 | $134,978,154 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $716,645,230 | 779,157 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $852,856,453 | 793,591 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $602,897,421 | 790,167 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $644,476,424 | 826,750 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $668,680,684 | 809,629 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $617,149,152 | 799,416 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $659,252,757 | 744,128 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $661,111,189 | 730,203 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $566,343,207 | 727,985 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $417,554,919 | 716,316 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $376,248,283 | 700,479 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $335,852,989 | 716,135 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $263,934,065 | 768,546 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $285,708,233 | 780,965 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $243,129,449 | 751,908 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $238,580,103 | 735,836 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $200,286,602 | 699,398 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $174,392,047 | 631,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $107,029,057 | 463,229 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $108,813,363 | 474,091 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $81,478,552 | 436,134 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $68,329,715 | 404,701 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $56,375,487 | 380,864 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $57,009,532 | 347,238 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $48,585,566 | 350,242 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||